Compare Abeona Therapeutics Inc (ABEO) vs Extra Space Storage, Inc. (EXR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Extra Space Storage, Inc. — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Extra Space Storage, Inc. trades at $144.92 (market cap $31.21B). The key difference: Extra Space Storage, Inc. is far larger — about 83.6× Abeona Therapeutics Inc's market cap, and Extra Space Storage, Inc. pays a 4.39% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | EXR | |
|---|---|---|
Market Cap | $373.32M | $31.21B |
Sector | Health | Real Estate |
52-Week High | $7.23 | $152.75 |
52-Week Low | $4.17 | $126.67 |
Enterprise Value | $228.22M | $45.01B |
Dividend Yield | — | 4.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
EXR trades at $147.73, down 1.04% on the day, with a neutral technical signal and strong fundamentals including a 27.66% net income margin and consistent earnings beats. The company maintains robust cash flow from operations at $1.85B in 2025 and recently priced $550 million in senior notes. Analyst consensus is mixed with a $152.86 price target, while technical support sits at $144.
Outlook remains stable with revenue growth and dividend reliability, but risks include high leverage with a 46.63% debt-to-asset ratio and competitive pressures. The stock offers value near consensus targets, though margin compression and interest rate sensitivity warrant caution for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →
